Abstract
Background:
Recombinant proteins overexpressed in E. coli are usually deposited in inclusion bodies. Cysteines in the protein contribute to this process. Inter- and intra- molecular disulfide bonds in chitinase, a cysteine-rich protein, cause aggregation when the recombinant protein is overexpressed in E. coli. Hence, aggregated proteins should be solubilized and allowed to refold to obtain native- or correctly- folded recombinant proteins.
Methods:
Dilution method that allows refolding of recombinant proteins, especially at high protein concentrations, is to slowly add the soluble protein to refolding buffer. For this purpose: first, the inclusion bodies containing insoluble proteins were purified; second, the aggregated proteins were solubilized; finally, the soluble proteins were refolded using glutathione redox system, guanidinium chloride, dithiothreitol, sucrose, and glycerol, simultaneously.
Results:
After protein solubilization and refolding, SDS-PAGE showed a 32 kDa band that was recognized by an anti-chitin antibody on western blots.
Conclusions:
By this method, cysteine-rich proteins from E. coli inclusion bodies can be solubilized and correctly folded into active proteins.
Key Words: Chitinase, Cysteine-rich proteins, Protein refolding, Protein solubilization
Introduction
Expression of recombinant proteins in E. coli is a fast, cost-effective, and high-throughput approach; however, the recombinant proteins are usually deposited in insoluble aggregated particles called inclusion bodies (1). If the recombinant protein contains cysteine (Cys) residues, which are able to form inter- and intra- molecular disulfide bonds and constitute the molecules with stable structure, protein aggregation as inclusion bodies can be anticipated. If the native or correctly-folded structure of the recombinant protein is desired, the aggregated proteins can be solubilized and refolded (2-4). Developing a protein-refolding procedure has been a fundamental problem in recombinant protein synthesis. Current strategies include dilution, dialysis, and chromatography (5). Using these methods, inclusion bodies at concentrations of 1-3 mg/ml can be separated from lysed bacterial cell suspensions by centrifugation (6, 7). The aggregated recombinant proteins can be solubilized and refolded using chaotropic agents such as guanidinium chloride (GdnCl), urea, or thiocyanate salts at high concentrations (8, 9), in combination with reducing agents such as 2-mercaptoethanol (2-ME), dithiothreitol (DTT), or cysteine (7, 10). These techniques yield similar results in inclusion bodies purification and protein solubilization; however protein refolding is limited in these systems. To obtain properly refolded Cys-rich proteins, redox buffers containing glutathione, L-cysteine, or cysteamine have been used. These compounds promote reshuffling of disulfide bonds and their use has resulted in high yields of naturally-folded proteins (7, 11).
Chitinases, as pathogenesis-related proteins (PR proteins), are one class of Cys-rich proteins that play crucial roles in allergies. Chitinases are produced in some plants, such as grape berry, which catalyze chitin as a homopolymer of N-acetyl-D-glucosamine as a defense against pathogenic microorganisms (12-15). The chitinase proteins contain chitin-binding domains with several conserved Cys residues that form disulfide bonds resulting in protein aggregation. Class IV chitinase, which is synthesized as grapes ripen and a major grape allergen (14, 16), is often produced as a recombinant protein for diagnosis and treatment of allergies (1, 16, 17). In this work, chitinase was investigated to develop an effective method of solubilization and refolding of Cys-rich recombinant proteins.
One method utilized to refold recombinant proteins slowly adds the unfolded soluble protein to refolding buffer. This method is applied in industry because of the broad applicability of the procedure in which a rotary shaker and peristaltic pumps are used (Fig. 1) (3). Here, we demonstrate that this dilution method of gradual addition of the Cys-rich recombinant protein into the refolding buffer improved the yield of the active form of the refolded protein over that of the un-refolded protein. This method could be useful in the solubilization and refolding of the other Cys-rich aggregated recombinant proteins from inclusion bodies.
Fig. 1.
schematic diagram of Cys-rich protein refolding by the dilution method. The unfolded protein is slowly added to refolding buffer with ~1 ml/hour flow rate with stirring at 200 rpm at 4 °C.
Materials and Methods
Expression and evaluation of the recombinant protein
The previously cloned chitinase IV was expressed using plasmid pET21b+ in E. coli BL21-CodonPlus (18). Chitinase IV expression was induced by the addition of isopropyl β-d-thiogalactopyranoside (IPTG) to a final concentration of 0.1 µg/ml and the bacteria were cultured in 600 ml of Luria-Bertani (LB) broth for 12 h at 18 °C. The bacteria were harvested by centrifugation at 7000 x g for 5 min at 4 °C (Fig. 2, step 1).
Fig. 2.
A detailed schematic process of inclusion body isolation followed by protein solubilization and refolding. (Step 2 was repeated two times).
Inclusion body isolation
The harvested bacterial pellet was resuspended in 3 ml of lysis buffer [3 ml lysis buffer/0.3 gram of E. coli (wet weight)] containing 50 mM Tris-HCl, pH 8.5, 100 mM KCl, and 2 M urea. To disrupt the bacteria thoroughly, the lysate was vortexed for 5 min and centrifuged at 9000 x g for 5 min at 4 °C. Following supernatant removal, the lysis step was repeated by adding 3 ml lysis buffer, vortexing for 1 min, and centrifuging at 9000 x g for 5 min at 4 °C (Fig. 2, step 2).
Protein solubilization
The pellet containing the inclusion bodies was resuspended in 5 ml of solubilization buffer consisting of 50 mM Tris-HCl, pH 8.5, 100 mM KCl, 5 M GdnCl, 1 mM EDTA, and 20 mM DTT. The mixture was vortexed for 1 min, incubated overnight at 4 °C, and incubated for 2 h at 37 °C. The solution was centrifuged at 9000 x g, for 10 min at 4 °C, the supernatant was collected for the protein refolding step (Fig. 2, step 3), and the pellet was saved for further analyses
Protein refolding
The 5 ml of solubilized recombinant protein was added to 300 ml of refolding buffer containing 50 mM Tris-HCl, pH 8.5, 0.4 M sucrose, 10% glycerol, 0.5% Triton X-100, 0.3 mM glutathione disulfide (GSSG), and 3 mM glutathione (GSH), at a rate of 1 ml/hour and stirred at 200 rpm at 4 °C. The mixture was then stirred for 24 h at 4 °C. The resulting solution was centrifuged at 9000 x g for 10 min at 4 °C and the supernatant was collected for protein purification (Fig. 2, step 4).
Refolded protein purification and dialysis
Recombinant chitinase IV was purified by metal affinity chromatography (Amersham Pharmacia Biotech) using step-by-step imidazole concentration. The affinity chromatography column with 5 ml of packed gel was washed with 100 ml of distilled water, 50 ml of 0.1 M nickel chloride solution, and 100 ml of distilled water, and then equilibrated with 100 ml of start buffer containing 50 mM Tris-HCl, pH 8.0, 0.5 M NaCl, and 5 mM imidazole. Sodium chloride and imidazole were added to the supernatant fraction of the refolded protein to final concentrations of 1.5 M and 5 mM, respectively, and this solution was applied to the chromatography column. The column was then washed with 200 ml of wash buffer [50 mM Tris-HCl, pH 8.0, 0.5 M NaCl] containing 5 mM imidazole and then with 200 ml of wash buffer containing 40 mM imidazole to remove contaminating bacterial proteins. Finally, the recombinant protein was eluted with 10 ml of elution buffer [50 mM Tris-HCl, pH 8.0, 0.5 M NaCl, and 500 mM imidazole] and dialyzed two times; first in 250 ml of phosphate buffered saline (PBS) with, and then without, 50% glycerol overnight at 4 °C.
Refolded protein electrophoresis and western blotting To evaluate the solubility of the solubilized recombinant protein, 10 µl of each fraction of the bacterial pellet, unfold-soluble protein before refolding process, and purified refolded protein of chitinase IV were separated by reducing 12.5% sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE) (Mini-Protean II Cell, Bio-Rad). The purified refolded protein was compared with the bacterial pellet and supernatant of insoluble protein by western blotting (Mini-Protean II Cell, Bio-Rad). The membrane was incubated with a primary anti-chitinase IV antibody (12) diluted 1:500 in 2% bovine serum albumin (BSA) in PBS overnight at 4°C and then with a 1:5000 dilution of horseradish peroxidase (HRP) conjugated goat anti-mouse secondary antibody (Bio-Rad, CA, USA). The immunocomplexes were visualized using the enhanced chemiluminescence (ECL) detection system (GE Healthcare, Buckinghamshire, UK).
Results
In this study, the previously cloned chitinase IV as a Cys-rich protein model was induced in E. coli. After centrifugation of the bacterial lysate, chitinase production was evaluated by SDS-PAGE of the bacterial pellet. Despite the low induction temperature of 18 °C, the SDS-PAGE showed an abundant 32 kDa band in the pellet fraction as aggregated protein (Fig. 3, lane A). There was no 32 kDa detectable band of chitinase in supernatant fraction of protein before solubilization and refolding procedures (Fig. 3, lane B). This result indicates that much of the induced protein was aggregated in inclusion bodies. After purification a single 32 kDa protein band of chitinase IV was present in the refolded protein fraction (Fig. 3, lane C).
Fig. 3.
SDS-PAGE analysis of chitinase IV expression in E. coli Bl21-CodonPlus. Lane M, protein molecular weight standards; lane A, bacterial pellet of induced E. coli; Lane B, supernatant fraction from induced E. coli before refolding procedure; Lane C, Purified refolded protein.
The purified refolded protein was analyzed by western blotting. The anti-chitinase IV antibody bound to a 32 kDa protein in all the fractions; however, the band was more intense in the purified re-folded fraction (Fig. 4, lane C) than in unfold-soluble protein before refolding process (Fig. 4, lane B). Western blotting results, which were belonging to protein fraction before refolding procedure, showed 66 kDa band that are likely dimmers of chitinase (Fig. 4 A and B).
Fig. 4.
Western blot analysis of chitinase IV expression in E. coli Bl21-CodonPlus. Lane M, protein molecular weight standards; lane A, bacterial pellet of induced E. coli; Lane B, supernatant fraction from induced E. coli before refolding procedure; Lane C, Purified refolded protein.
Discussion
Recombinant proteins, especially Cys-rich ones, are usually expressed in inclusion bodies of E. coli as insoluble or aggregated proteins. Insoluble proteins must be solubilized and then refolded to achieve their soluble and active forms. Protein solubilization and refolding methods include dilution, dialysis, and chromatography (5), which are similar in inclusion bodies purification and protein solubilization efficiency, but differ in protein refolding efficiency (7, 11). In this study, we evaluated a dilution procedure to refold Cys-rich proteins using refolding buffer containing glutathione as a redox system, guanidinium chloride, dithiothreitol, sucrose, and glycerol, simultaneously.
In the solubilization procedure, GdnCl as a denaturant at high concentration is able to solubilized aggregated protein in inclusion bodies through decreased oxidation of -SH groups and isomerization of disulfide bonds (19). Although GdnCl at high concentration is necessary for solubilization, it can interfere with correct protein folding; therefore, it must be removed prior to the protein refolding (19). Because the soluble protein was precipitated in the absence of GdnCl, the refolding step was performed at a low concentration of guanidine hydrochloride (3, 19). As mentioned above, EDTA, as a chelating agent, can be used in the solubilization to chelate metal ions and inhibit unwanted oxidation reactions. Dithiothreitol is the other agent in solubilization buffer that can keep cysteine in its reduced form and prevent disulfide bonding during solubilization (7).
In Cys-rich proteins, constitution of disulfide bonds resulting in formation of dimmer structures of proteins. In the refolding procedure oxidation of disulfide bonds can be triggered by the thiol group of glutathione, as a redox system (oxido-shuffling reagents), that exists in both the reduced and oxidized forms (GSH and GSSG). (20-22). In consistent with this idea, there was a 66 kDa band in our western blotting results of protein fraction before refolding procedure, which are likely dimmers of chitinase. While after refolding procedure by reduction in the solubilization/refolding process, the 66 kDa protein band was disappeared. Hence, disappearing of 66 kDa band of chitinase in the western blotting results of refolded protein indicated that chitinase was in normal condition without dimmer structures. Tsuji and colleagues applied glutathione to refold reduced IL-2 in oxidative fashion successfully. The high cost of glutathione as an oxido-shuffling reagent is a disadvantage to its use in the protein refolding process (21).
Sucrose, as low molecular weight additive, and both ionic (sodium dodecyl sulfate (SDS)) and non-ionic (Triton X-100, Tween 20, and Tween 80) detergents can enhance protein refolding yields through the suppression of protein aggregation in refolding buffers. Jason and colleagues showed that the yield of protein refolding can be increased by the use of additives such as 500 mM sucrose, 0.1% Tween 20, and 500 mM Tris, in the refolding process (23). On the other hand, glycerol as a protein stabilizer can prevent protein aggregation in the refolding process, which reduces the refolding buffer turbidity (24). Tris concentrations greater than 0.4 M can enhance renaturation yields via inhibition of protein aggregation (25-27).
Because proteins, especially Cys-rich ones, are prone to aggregate at high concentrations, the dilution procedure may be the method of choice for refolding of highly-concentrated proteins. For this purpose, the soluble protein is slowly added to the refolding buffer drop-by-drop with stirring, which leads to intramolecular rather than intermolecular interactions. To achieve high refolding yields with low protein aggregation, the temperature, the rate of protein addition, and the volume ratio of the refolding buffer to the unfolded protein must be carefully maintained. The dilution procedure has been successfully applied for the refolding of Pseudomonas exotoxin recombinant proteins (24). Dialysis is recommended after protein refolding to remove any reducing and/or oxidizing agents from the protein mixture. Further manipulation of the current procedure for protein refolding to improve refolded protein yields has been performed with other additives such as acetone, acetoamide, dimethylsulfoxide, and polyethyleneglycol (28, 29).
In conclusion, this study has demonstrated that Cys-rich recombinant proteins can be refolded using dilution method as a simple and efficient procedure and refolding buffer containing glutathione, guanidinium chloride, dithiothreitol, sucrose, and glycerol, simultaneously. The SDS-PAGE and western blotting results indicated that the protein was soluble and refolded in compare with supernatant fraction of protein before refolding procedure. In the future, it will be necessary to determine the quantitative yield of protein refolding by the dilution method with different additives one at a time to achieve protein refolding with optimum yields.
Acknowledgements
This research was supported and funding by Immunology Research Center, Medical School, Mashhad University of Medical Sciences, Mashhad, Iran.
References
- 1.Fernandez-Caballero C, Romero I, Goni O, Escribano MI, Merodio C, Sanchez-Ballesta MT. Characterization of an antifungal and cryoprotective class I chitinase from table grape berries (Vitis vinifera Cv Cardinal) Journal of agricultural and food chemistry. 2009;57(19):8893–900. doi: 10.1021/jf9016543. [DOI] [PubMed] [Google Scholar]
- 2.De Bernardez Clark E. Refolding of recombinant proteins. Current Opinion in Biotechnology. 1998;9(2):157–63. doi: 10.1016/s0958-1669(98)80109-2. [DOI] [PubMed] [Google Scholar]
- 3.Jungbauer A, Kaar W. Current status of technical protein refolding. Journal of biotechnology. 2007;128(3):587–96. doi: 10.1016/j.jbiotec.2006.12.004. [DOI] [PubMed] [Google Scholar]
- 4.Wingfield PT, Palmer I, Liang SM. Folding and purification of insoluble (inclusion body) proteins from Escherichia coli. Current protocols in protein science. 1995;6(5):1–6. doi: 10.1002/0471140864.ps0605s78. [DOI] [PubMed] [Google Scholar]
- 5.Middelberg AP. Preparative protein refolding. Trends in Biotechnology. 2002;20(10):437–43. doi: 10.1016/s0167-7799(02)02047-4. [DOI] [PubMed] [Google Scholar]
- 6.Mukhopadhyay A. Inclusion bodies and purification of proteins in biologically active forms. Biotreatment, Downstream Processing and Modelling. Springer; 1997. pp. 61–109. [DOI] [PubMed] [Google Scholar]
- 7.Lilie H, Schwarz E, Rudolph R. Advances in refolding of proteins produced in E coli. Current Opinion in Biotechnology. 1998;9(5):497–501. doi: 10.1016/s0958-1669(98)80035-9. [DOI] [PubMed] [Google Scholar]
- 8.Fischer B, Sumner I, Goodenough P. Isolation, renaturation, and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies. Biotechnology and bioengineering. 1993;41(1):3–13. doi: 10.1002/bit.260410103. [DOI] [PubMed] [Google Scholar]
- 9.Rudolph R, Lilie H. In vitro folding of inclusion body proteins. The FASEB Journal. 1996;10(1):49–56. [PubMed] [Google Scholar]
- 10.Patra AK, Mukhopadhyay R, Mukhija R, Krishnan A, Garg L, Panda AK. Optimization of Inclusion Body Solubilization and Renaturation of Recombinant Human Growth Hormone from Escherichia coli. Protein expression and purification. 2000;18(2):182–92. doi: 10.1006/prep.1999.1179. [DOI] [PubMed] [Google Scholar]
- 11.Wetlaufer DB, Branca PA, Chen G-X. The oxidative folding of proteins by disulfide plus thiol does not correlate with redox potential. Protein engineering. 1987;1(2):141–6. doi: 10.1093/protein/1.2.141. [DOI] [PubMed] [Google Scholar]
- 12.Soukhtanloo M, Falak R, Sankian M, Varasteh A-R. Generation and characterization of anti-chitinase monoclonal antibodies. Hybridoma. 2011;30(2):145–51. doi: 10.1089/hyb.2010.0088. [DOI] [PubMed] [Google Scholar]
- 13.Vassilopoulou E, Zuidmeer L, Akkerdaas J, Tassios I, Rigby NR, Mills EC, et al. Severe immediate allergic reactions to grapes: part of a lipid transfer protein-associated clinical syndrome. International archives of allergy and immunology. 2007;143(2):92–102. doi: 10.1159/000098657. [DOI] [PubMed] [Google Scholar]
- 14.Pastorello EA, Farioli L, Pravettoni V, Ortolani C, Fortunato D, Giuffrida MG, et al. Identification of grape and wine allergens as an endochitinase 4, a lipid-transfer protein, and a thaumatin. Journal of allergy and clinical immunology. 2003;111(2):350–9. doi: 10.1067/mai.2003.35. [DOI] [PubMed] [Google Scholar]
- 15.Collinge DB, Kragh KM, Mikkelsen JD, Nielsen KK, Rasmussen U, Vad K. Plant chitinases. The Plant Journal. 1993;3(1):31–40. doi: 10.1046/j.1365-313x.1993.t01-1-00999.x. [DOI] [PubMed] [Google Scholar]
- 16.Robinson SP, Jacobs AK, Dry IB. A class IV chitinase is highly expressed in grape berries during ripening. Plant Physiology. 1997;114(3):771–8. doi: 10.1104/pp.114.3.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hamel F, Boivin R, Tremblay C, Bellemare G. Structural and evolutionary relationships among chitinases of flowering plants. Journal of molecular evolution. 1997;44(6):614–24. doi: 10.1007/pl00006184. [DOI] [PubMed] [Google Scholar]
- 18.Falak R, Varasteh A, Ketabdar H, Sankian M. Expression of grape class IV chitinase in Spodoptera frugiperda (Sf9) insect cells. Allergologia et immunopathologia. 2013 doi: 10.1016/j.aller.2012.11.004. [DOI] [PubMed] [Google Scholar]
- 19.Tsuji T, Nakagawa R, Sugimoto N, Fukuhara K. Characterization of disulfide bonds in recombinant proteins: reduced human interleukin 2 in inclusion bodies and its oxidative refolding. Biochemistry. 1987;26(11):3129–34. doi: 10.1021/bi00385a028. [DOI] [PubMed] [Google Scholar]
- 20.Carpenter JF, Kendrick BS, Chang BS, Manning MC, Randolph TW. Inhibition of stress-induced aggregation of protein therapeutics. Methods in enzymology. 1999:309–236. doi: 10.1016/s0076-6879(99)09018-7. [DOI] [PubMed] [Google Scholar]
- 21.Clark EDB. Protein refolding for industrial processes. Current Opinion in Biotechnology. 2001;12(2):202–7. doi: 10.1016/s0958-1669(00)00200-7. [DOI] [PubMed] [Google Scholar]
- 22.Ahmed AK, Schaffer S, Wetlaufer D. Nonenzymic reactivation of reduced bovine pancreatic ribonuclease by air oxidation and by glutathione oxidoreduction buffers. Journal of Biological Chemistry. 1975;250(21):8477–82. [PubMed] [Google Scholar]
- 23.Ho JG, Middelberg AP. Estimating the potential refolding yield of recombinant proteins expressed as inclusion bodies. Biotechnology and bioengineering. 2004;87(5):584–92. doi: 10.1002/bit.20148. [DOI] [PubMed] [Google Scholar]
- 24.Buchner J, Pastan I, Brinkmann U. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Analytical biochemistry. 1992;205(2):263–70. doi: 10.1016/0003-2697(92)90433-8. [DOI] [PubMed] [Google Scholar]
- 25.Kerwin BA, Heller MC, Levin SH, Randolph TW. Effects of tween 80 and sucrose on acute short-term stability and long-term storage at −20 °C of a recombinant hemoglobin. Journal of Pharmaceutical Sciences. 1998;87(9):1062–8. doi: 10.1021/js980140v. [DOI] [PubMed] [Google Scholar]
- 26.Armstrong N, Lencastre AD, Gouaux E. A new protein folding screen: application to the ligand binding domains of a glutamate and kainate receptor and to lysozyme and carbonic anhydrase. Protein Science. 1999;8(7):1475–83. doi: 10.1110/ps.8.7.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.De Bernardez Clark E, Schwarz E, Rudolph R. Inhibition of aggregation side reactions during in vitro protein folding. Methods in enzymology. 1999;309:217–36. doi: 10.1016/s0076-6879(99)09017-5. [DOI] [PubMed] [Google Scholar]
- 28.Yasuda M, Murakami Y, Sowa A, Ogino H, Ishikawa H. Effect of additives on refolding of a denatured protein. Biotechnology progress. 1998;14(4):601–6. doi: 10.1021/bp9800438. [DOI] [PubMed] [Google Scholar]
- 29.Singh SM, Panda AK. Solubilization and refolding of bacterial inclusion body proteins. Journal of bioscience and bioengineering. 2005;99(4):303–10. doi: 10.1263/jbb.99.303. [DOI] [PubMed] [Google Scholar]




